Inventor · disambiguated record
Kevin Mcgrath
Also filed as: MCGRATH KEVIN · MCGRATH KEVIN P · MCGRATH KEVIN ROBERT
12 granted patents·8 pending applications·41 citations·filing 2001–2025
88Inventor score
Top patents by PatentIndex Score
20 records- 0196US11505558B1Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2021·Granted Nov 22, 2022·8 cites·21 claims
- 0295US11912695B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2022·Granted Feb 27, 2024·5 cites·20 claims
- 0395US11572367B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2020·Granted Feb 7, 2023·9 cites·21 claims
- 0495US11254664B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Feb 22, 2022·7 cites·19 claims
- 0594US12006326B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Granted Jun 11, 2024·3 cites·18 claims
- 0694US11945830B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Granted Apr 2, 2024·3 cites·18 claims
- 0781US12509470B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2024·Granted Dec 30, 2025·0 cites·8 claims
- 0878US7053046B2Peptide activators of VEGFMCGRATH KEVIN·Filed 2001·Granted May 30, 2006·6 cites·5 claims
- 0978US2024360117A1Benzodiazepine derivatives as rsv inhibitorsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 1074US12358921B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2023·Granted Jul 15, 2025·0 cites·16 claims
- 1169US2025368659A1Antiviral Heterocyclic CompoundsENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 1266US2024368174A1Antiviral Heterocyclic CompoundsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 1360US11945824B2Heterocyclic compounds as anti-viral agentsENANTA PHARM INC·Filed 2021·Granted Apr 2, 2024·0 cites·21 claims
- 1459US10759816B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Sep 1, 2020·0 cites·20 claims
- 1557US2023115580A1Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Application pending·0 cites
- 1655US2017226129A1Heterocyclic compounds as rsv inhibitorsENANTA PHARM INC·Filed 2017·Application pending·0 cites
- 1752US2025313569A1Pharmaceutical Compounds And Compositions As Modulators Of MAS-Related G-Protein Receptor X2ENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 1847US2011296757A1Portable Hydroponic Terrace CartMCGRATH KEVIN ROBERT·Filed 2010·Application pending·0 cites
- 1945US2006000034A1Textile ink compositionMCGRATH KEVIN P·Filed 2004·Application pending·0 cites
- 2044US11091501B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Aug 17, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Mcgrath files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →